Amgen Inc.
FORMULATIONS
Last updated:
Abstract:
The invention provides a formulation comprising a buffer with a pH from about 4.0 to about 6.0, proline and an effective amount of a polypeptide. The polypeptide can be an antibody. The specification also provides methods of preparing the formulation, a kit containing the formulation and methods of using the formulation.
Status:
Application
Type:
Utility
Filling date:
22 May 2019
Issue date:
14 Nov 2019